These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Kim HJ; Kim PK; Yoo HS; Kim CW Clin Biochem; 2012 Jan; 45(1-2):60-7. PubMed ID: 22040812 [TBL] [Abstract][Full Text] [Related]
5. Combined Methods for Diabetic Retinopathy Screening, Using Retina Photographs and Tear Fluid Proteomics Biomarkers. Torok Z; Peto T; Csosz E; Tukacs E; Molnar AM; Berta A; Tozser J; Hajdu A; Nagy V; Domokos B; Csutak A J Diabetes Res; 2015; 2015():623619. PubMed ID: 26221613 [TBL] [Abstract][Full Text] [Related]
6. Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis. Amorim M; Martins B; Caramelo F; Gonçalves C; Trindade G; Simão J; Barreto P; Marques I; Leal EC; Carvalho E; Reis F; Ribeiro-Rodrigues T; Girão H; Rodrigues-Santos P; Farinha C; Ambrósio AF; Silva R; Fernandes R Front Med (Lausanne); 2022; 9():873483. PubMed ID: 35692536 [TBL] [Abstract][Full Text] [Related]
7. Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics. Jin J; Min H; Kim SJ; Oh S; Kim K; Yu HG; Park T; Kim Y J Diabetes Res; 2016; 2016():6571976. PubMed ID: 26665153 [TBL] [Abstract][Full Text] [Related]
8. Tear Proteomics in Children and Adolescents with Type 1 Diabetes: A Promising Approach to Biomarker Identification of Diabetes Pathogenesis and Complications. Angelopoulou E; Kitani RA; Stroggilos R; Lygirou V; Vasilakis IA; Letsou K; Vlahou A; Zoidakis J; Samiotaki M; Kanaka-Gantenbein C; Nicolaides NC Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337483 [TBL] [Abstract][Full Text] [Related]
9. Tear Protein Markers for Diabetic Retinopathy and Diabetic Macular Edema - Towards an Early Diagnosis and Better Prognosis. Sharma S; Belenje A; Takkar B; Narula R; Rathi VM; Tyagi M; Rani PK; Narayanan R; Kaur I Semin Ophthalmol; 2024 Aug; 39(6):440-450. PubMed ID: 38643349 [TBL] [Abstract][Full Text] [Related]
11. Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities - preliminary data for PPPM validation. Kropp M; De Clerck E; Vo TKS; Thumann G; Costigliola V; Golubnitschaja O EPMA J; 2023 Mar; 14(1):43-51. PubMed ID: 36845280 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Proteomic Profiling of Patients' Tears Identifies Potential Biomarkers for the Traumatic Vegetative State. Tang Q; Zhang C; Wu X; Duan W; Weng W; Feng J; Mao Q; Chen S; Jiang J; Gao G Neurosci Bull; 2018 Aug; 34(4):626-638. PubMed ID: 30019218 [TBL] [Abstract][Full Text] [Related]
13. Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review). Ma JYW; Sze YH; Bian JF; Lam TC Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760148 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Kaštelan S; Orešković I; Bišćan F; Kaštelan H; Gverović Antunica A Biochem Med (Zagreb); 2020 Oct; 30(3):030502. PubMed ID: 32774120 [TBL] [Abstract][Full Text] [Related]
15. Tear Proteomics in Keratoconus: A Quantitative SWATH-MS Analysis. López-López M; Regueiro U; Bravo SB; Chantada-Vázquez MDP; Varela-Fernández R; Ávila-Gómez P; Hervella P; Lema I Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):30. PubMed ID: 34431975 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. Csősz É; Boross P; Csutak A; Berta A; Tóth F; Póliska S; Török Z; Tőzsér J J Proteomics; 2012 Apr; 75(7):2196-204. PubMed ID: 22300579 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis. Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643 [TBL] [Abstract][Full Text] [Related]
18. Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Park KS; Kim SS; Kim JC; Kim HC; Im YS; Ahn CW; Lee HK Am J Ophthalmol; 2008 Mar; 145(3):432-7. PubMed ID: 18282491 [TBL] [Abstract][Full Text] [Related]
19. Tear Fluid Progranulin as a Noninvasive Biomarker for the Monitoring of Corneal Innervation Changes in Patients With Type 2 Diabetes Mellitus. Zhou T; Dou Z; Cai Y; Zhu D; Fu Y Transl Vis Sci Technol; 2024 Jul; 13(7):9. PubMed ID: 38984913 [TBL] [Abstract][Full Text] [Related]
20. Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects. Xuan Q; Ouyang Y; Wang Y; Wu L; Li H; Luo Y; Zhao X; Feng D; Qin W; Hu C; Zhou L; Liu X; Zou H; Cai C; Wu J; Jia W; Xu G Adv Sci (Weinh); 2020 Nov; 7(22):2001714. PubMed ID: 33240754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]